Bluefin Capital Management, LLC Merck & Co., Inc. Call Options Transaction History

Bluefin Capital Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $6.28 Million - $7.29 Million	56,500 New	56,500 $6.42 Million
Q4 2023 Feb 16, 2024	BUY	$100.18 - $109.02 $3.68 Million - $4 Million	36,700 Added 367.0%	46,700 $5.09 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $1.03 Million - $1.14 Million	10,000 New	10,000 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $3.44 Million - $4.31 Million	47,600 New	47,600 $5,000

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.